Indian generic drug maker Dr. Reddy's Labs has appointed G.V. Prasad as chairman of the company, Dr. Reddy's said.

Generic drug maker Dr. Reddy's Labs has launched a drug used to treat certain cancers, the company said Tuesday.

The Food and Drug Administration has given tentative approval to a generic drug for treating hypertension, according to agency records.

Novo Nordisk has appointed Curtis Oltmans as its corporate VP and general counsel for legal and quality affairs, the company said Friday.

Dr. Reddy's Labs has appointed a new CFO and head of its North America business, the generic drug maker said.

The year 2012 is coming to an end, and it’s been a big year for 
generic drugs.


Dr. Reddy's Labs has launched a generic drug for treating asthma and allergies, and preventing bronchospasm during exercise, the company said.

For branded drug makers, the pharmaceutical patent cliff has never loomed higher or steeper. The exposure of so many of the world’s biggest-selling medicines to generic competition for the first time is redefining the pricing model for many of the most widely prescribed classes of pharmaceuticals.

The U.S. healthcare system presents a paradox: It’s the most expensive system in the world, and yet it produces among the worst results among developed countries.

Dr. Reddy's Labs has launched a generic version of a popular cholesterol drug.

Dr. Reddy's Labs has launched a drug for treating Parkinson's disease, the company said Thursday.